Abstract

Pneumatosis coli (PC) is the radiological finding of gas within the wall of the colon. We present the case of a middle-aged woman admitted acutely with abdominal bloating and right-sided abdominal pain. Background included chronic back pain and constipation managed with long term methadone and high dose lactulose, respectively, and symptoms of abdominal bloating with increased flatulence. On abdominal examination there was right sided peritonism. Vital signs and bloods were normal. Computed tomography (CT) abdomen showed subserosal and submucosal air locules in the right colon, and a small volume of pneumoperitoneum. PC secondary to lactulose was suspected. Lactulose was ceased, and intravenous antibiotics given to suppress bacterial translocation. The patient symptomatically improved and was discharged on oral metronidazole. Her symptoms rapidly resolved and a CT scan at 6 weeks was normal. Clinically, the diagnosis of PC helped to prevent unnecessary acute surgery and allowed successful medical management to be initiated.

Introduction

Pneumatosis coli (PC) is the radiological finding of gas within the wall of the colon. Whilst previously a rare entity, its incidence is increasing which may be partly due to the increasing use and availability of computed tomography (CT) scanning [1, 2]. PC may be idiopathic (primary)—often asymptomatic—or linked to causative pathology (secondary), such as inflammatory, infective, and ischaemic conditions, and occasionally by medications such as lactulose. The spectrum of clinical presentation is broad, ranging from an incidental finding to presentation with an acute abdomen. Management is therefore determined by patient symptoms, clinical status, and the underlying aetiology [2, 3].

Case report

A woman in her 50s presented to the Emergency Department with a 1-week history of worsening right sided abdominal pain. Background included chronic back pain managed with long term methadone 100 mg once daily, and previous hepatitis C treated 9 years earlier with pegylated interferon and ribavirin. There was no history of vascular disease. She was taking lactulose 50 mL once daily to treat constipation secondary to methadone and described longstanding issues with abdominal discomfort, bloating, and frequent flatulence. She was living independently with her family, was an ex-smoker and previous IV drug user. On examination she was in some distress. Her vital signs were all normal. Abdominal examination revealed peritonism in the right abdomen. Blood tests showed normal inflammatory markers with a white cell count of 6.2 × 109/L, neutrophils of 2.8 × 109/L, and a C-reactive protein (CRP) of 6 mg/L. A CT abdomen was performed and was reported to show free air, which on review showed multiple subserosal and submucosal locules of air in the caecum and ascending colon, and a small volume of intra-abdominal free air with no free fluid. There were no other features to suggest ischaemia and no colonic diverticulosis (Fig. 1).

Coronal and axial CT slices showing pneumatosis in the right colon. Arrowheads demonstrate subserosal and submucosal gas.
Figure 1

Coronal and axial CT slices showing pneumatosis in the right colon. Arrowheads demonstrate subserosal and submucosal gas.

The main differential diagnosis was between an acute abdomen with ischaemia of the right colon versus PC secondary to high dose lactulose. The degree of pain, patient distress, and localized peritonism with free air in the peritoneal cavity and air in the wall of the right colon was consistent with an acute abdomen. However, the normal vital signs and CRP of 6 mg/L suggested otherwise. The background of high dose lactulose, abdominal bloating and increased flatus, combined with the pattern of submucosal and subserosal air led to a provisional diagnosis of PC secondary to high dose lactulose being made. This resulted in a trial of medical treatment and avoidance of an acute laparoscopy or laparotomy.

Initial treatment involved serial abdominal examination to monitor progress, stopping the lactulose, and commencing IV cefuroxime 1.5 g 8-hourly and metronidazole 500 mg 12-hourly to suppress bacterial translocation. On repeat review the patient did not deteriorate. Her symptoms of abdominal pain, bloating, and flatus, and her clinical signs of peritonism were all improving within 24 h. There was ongoing clinical improvement and a repeat CT abdomen and pelvis at 48 h showed a reduction in colonic pneumatosis and pneumoperitoneum. She was discharged on a 2-week course of oral metronidazole 400 mg twice daily. Macrogol 3350 (molaxole) sachets once daily were used for treatment of her constipation instead of lactulose and the use of probiotics to maintain a healthy gut microbiome was advised. Over the subsequent 2 weeks her abdominal pain, bloating, and excessive flatulence completely resolved—for the first time in over 2 years. An interval CT scan at 6 weeks showed no evidence of pneumatosis or pneumoperitoneum (Fig. 2). At surgical outpatient clinic follow up at 3 months she remained symptom free and was grateful to no longer be troubled by her previously persistent abdominal symptoms.

Follow up coronal and axial CT slices at 6 weeks showing resolution of PC.
Figure 2

Follow up coronal and axial CT slices at 6 weeks showing resolution of PC.

Discussion

Whilst the pathogenesis of PC is likely multifactorial three main theories have been proposed. The ``mechanical'' theory suggests that gas may enter the wall of the bowel through breaks in the mucosa or via the serosal surface by tracking along mesenteric blood vessels. The “bacterial” theory proposes that gas-forming bacteria may invade the submucosa due to increased mucosal permeability or through mucosal defects [3, 4]. The “biochemical” theory, which is consistent with our case, states that luminal bacteria can produce large volumes of hydrogen and carbon dioxide gas via fermentation of carbohydrates. As the gas pressure in the bowel lumen increases, this may diffuse into the bowel wall leading to PC [5, 6]. This may result in submucosal and subserosal cysts, with subserosal cyst rupture resulting in pneumoperitoneum, a finding reported in one in five patients with PC [7].

Lactulose, a synthetic non-absorbable disaccharide, is split by bacteria into its component monosaccharides thus providing them with a fuel source, and this effect is exacerbated by slow bowel transit. Through this breakdown process hydrogen and carbon dioxide gases are released, thus potentially leading to PC as per the “biochemical” theory [5, 6]. Methogenic and sulphate reducing bacteria, which are capable of consuming hydrogen gas, protect against PC [8]. Removing lactulose will usually result in a clinical improvement in 2–3 days [5]. Whilst PC most often involves the sigmoid and descending colon [9], in our case the right colon was predominantly affected, and this may be a feature associated with lactulose use [10].

Several cases of PC attributable to lactulose therapy have been reported previously [5, 10, 11]. These usually involve patients with established chronic liver disease and cirrhosis, and cases with pneumoperitoneum have been described. Our patient had a history of previous hepatitis C successfully treated although there was no evidence of liver cirrhosis or chronic liver disease. Clinically, the combination of high dose lactulose, increased flatulence and bloating, normal observations and bloods, and the pattern of gas on the CT supported a diagnosis of PC which could be managed medically without an acute surgical intervention. The CT finding of pericolic air, which on review was confirmed to be subsersoal air, helped to confirm the diagnosis. Cessation of lactulose and a course of oral metronidazole resulted in complete symptomatic and radiological resolution.

Conflict of interest statement

None declared.

Funding

None declared.

References

1.

Heng
 
Y
,
Schuffler
 
MD
,
Haggitt
 
RC
, et al.  
Pneumatosis intestinalis: a review
.
Am J Gastroenterol
 
1995
;
90
:
1747
58
.

2.

Knechtle
 
SJ
,
Davidoff
 
AM
,
Rice
 
RP
.
Pneumatosis intestinalis. Surgical management and clinical outcome
.
Ann Surg
 
1990
;
212
:
160
5
. .

3.

St Peter
 
SD
,
Abbas
 
MA
,
Kelly
 
KA
.
The spectrum of pneumatosis intestinalis
.
Arch Surg
 
2003
;
138
:
68
75
. .

4.

Galandiuk
 
S
,
Fazio
 
VW
.
Pneumatosis cystoides intestinalis. A review of the literature
.
Dis Colon Rectum
 
1986
;
29
:
358
63
. .

5.

Goodman
 
RA
,
Riley
 
TR
 3rd.
 
Lactulose-induced pneumatosis intestinalis and pneumoperitoneum
.
Dig Dis Sci
 
2001
;
46
:
2549
53
. .

6.

Levitt
 
MD
,
Olsson
 
S
.
Pneumatosis cystoides intestinalis and high breath H2 excretion: insights into the role of H2 in this condition
.
Gastroenterology
 
1995
;
108
:
1560
5
. .

7.

Thomson
 
WO
,
Gillespie
 
G
,
Blumgart
 
LH
.
The clinical significance of pneumatosis cystoides intestinalis: a report of 5 cases
.
Br J Surg
 
1977
;
64
:
590
2
. .

8.

Christl
 
SU
,
Gibson
 
GR
,
Murgatroyd
 
PR
, et al.  
Impaired hydrogen metabolism in pneumatosis cystoides intestinalis
.
Gastroenterology
 
1993
;
104
:
392
7
. .

9.

Chippindale
 
AJ
,
Desai
 
S
.
Two unusual cases of pneumatosis coli
.
Clin Radiol
 
1991
;
43
:
180
2
. .

10.

Ullah
 
KI
,
Jen
 
H
,
Collazo
 
T
.
Lactulose induced pneumatosis and pneumoperitoneum: a case report: 2440
.
Off J Am College Gastroenterol | ACG
 
2018
;
113
:
S1359
S60
. .

11.

Varelas
 
LJ
,
Klinge
 
MJ
,
Malik
 
SM
, et al.  
Idiopathic pneumatosis intestinalis secondary to lactulose use in patients with cirrhosis
.
J Gastroenterol Hepatol
 
2020
;
35
:
1065
8
. .

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.